Rupal P. O'Quinn, MD, MHCI, FACC
Associate Professor of Clinical Medicine (Cardiovascular Medicine)
Director of Cardio-Oncology, Penn Presbyterian Medical Center
Associate Program Director, Penn Cardiovascular Disease Fellowship Program, University of Pennsylvania
Department: Medicine
Contact information
Heart and Vascular Pavilion
51 N. 39th Street, 4th Floor
Philadelphia, PA 19104
51 N. 39th Street, 4th Floor
Philadelphia, PA 19104
Office: 215-662-9189
Education:
BS (Bachelor of Science in Human Physiology (Summa Cum Laude)
Boston University, Boston, Massachusetts, 2002.
MD (Doctor of Medicine)
Rutgers Medical School/University of Medicine and Dentistry of New Jersey, 2007.
MHCI (Master of Health Care Innovation)
University of Pennsylvania, 2023.
Permanent linkBS (Bachelor of Science in Human Physiology (Summa Cum Laude)
Boston University, Boston, Massachusetts, 2002.
MD (Doctor of Medicine)
Rutgers Medical School/University of Medicine and Dentistry of New Jersey, 2007.
MHCI (Master of Health Care Innovation)
University of Pennsylvania, 2023.
Description of Clinical Expertise
Cardiac complications of cancer treatment, echocardiography, cardiac magnetic resonance, healthcare innovationDescription of Research Expertise
Cardiac complications of cancer treatment; Health Care InnovationSelected Publications
Vallabhaneni S, Adusumalli S, Wu J, Groeneveld PW, Gerson J, O'Quinn RP. : Cardiotoxicity from bruton tyrosine kinase inhibitors (BTKi)-an analysis of an administrative health claims database. Cardiooncology June 2024.Yegya-Raman N, Ho Lee S, Friedes C, Wang X, Iocolano M, Kegelman TP, Duan L, Li B, Berlin E, Kim KN, Doucette A, Denduluri S, Levin WP, Cengel KA, Cohen RB, Langer CJ, Kevin Teo BK, Zou W, O'Quinn RP, Deasy JO, Bradley JD, Sun L, Ky B, Xiao Y, Feigenberg SJ.: Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation. Radiother Oncol. 2024 2024.
Yegya-Raman N, Kegelman TP, Ho Lee S, Kallan MJ, Kim KN, Natarajan J, Deek MP, Zou W, O'Reilly SE, Zhang Z, Levin W, Cengel K, Kao G, Cohen RB, Sun LL, Langer CJ, Aggarwal C, Singh AP, O'Quinn R, Ky B, Apte A, Deasy J, Xiao Y, Berman AT, Jabbour SK, Feigenberg SJ: Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer. Clin Transl Radiat Oncol. January 2023.
Fanaroff AC, Coratti S, Halaby R, Sanghavi M, O'Quinn RP, Krishnan S, Glassberg H, Bajaj A, Adusumalli S, Chokshi N, Patel MS. : Feasibility and outcomes from using a commitment devices and text message reminders to increase adherence to time-restricted eating: A randomized trial. Am Heart J. January 2023.
O’Quinn R, Corry AJ, Bajwa N, et al. : Longitudinal review of cardiac events with acalabrutinib in the treatment of chronic lymphocytic leukemia (CLL) using data from 3 phase 3 randomized controlled trials. Presented at: 2023 International Workshop on CLL; October 6-9, 2023; Boston, Massachusetts. Abstract 1552457. 2023.
Vidula, MK, O’Quinn R, Sanghavi M, Litt H, Han Y, Bravo PE. : Not All That Glitters Is Sarcoidosis: Septal Perforator Myocardial Infarction Mimicking Isolated Cardiac Sarcoidosis. Circ Cardiovasc Imaging June 2022.
Herrmann J, Lenihan D, Armenian S, Barac A, Blaes A, Cardinale D, Carver J, Dent S, Ky B, Lyon AR, López-Fernández T, Fradley MG, Ganatra S, Curigliano G, Mitchell JD, Minotti G, Lang NN, Liu JE, Neilan TG, Nohria A, O'Quinn R, Pusic I, Porter C, Reynolds KL, Ruddy KJ, Thavendiranathan P, Valent P. : Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. European Heart Journal December 2021.
Freyer CW, Fradley M, Madnick D, Carver JR, Frey NV, Gill SI, Ky B, Luger SM, Martin ME, McCurdy SR, O'Quinn R, Perl AE, Stadtmauer EA, Loren AW. : Characterization of Pericarditis Following Allogeneic Hematopoietic Cell Transplant. Transplant Cell Ther(27), Nov 2021 Notes: doi: 10.1016/j.jtct.2021.07.025. Online ahead of print.
Freyer CW, Fradley M, Madnick D, Carver JR, Frey NV, Gill SI, Ky B, Luger SM, Martin ME, McCurdy SR, O’Quinn R, Perl AE, Stadtmauer EA, Loren AW. : Characterization of Pericarditis following Allogeneic Hematopoietic Cell Transplantation. Transplant Cell Ther. July 2021.
Rao VU, Reeves DJ, Chugh AR, O'Quinn R, Fradley MG, Raghavendra M, Dent S, Barac A, Lenihan D: Clinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents: JACC State-of-the-Art Review. Journal of the American College of Cardiology 77(21): 2693-2716, June 2021.